High‐dose intravenous immunoglobulin as adjuvant treatment for grade IV acute cutaneous graft‐versus‐host disease-Reference-Cited by-同舟云学术

High‐dose intravenous immunoglobulin as adjuvant treatment for grade IV acute cutaneous graft‐versus‐host disease

Published:2019-08-18 Issue:4 Volume:181 Page:869-871
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Blanchard S.K.¹,Sullivan K.M.²³,Hooten J.N.¹,Holcomb Z. E.⁴,Rowe Nichols K.²,Selim M.A.¹⁵,Rao C.L.¹⁶,Hall R.P.¹^ORCID,Chao N.J.²³,Cardones A.R.¹³⁶^ORCID

Affiliation:

1. Department of Dermatology Duke University Medical Center Durham NC U.S.A.

2. Division of Hematological Malignancies and Cellular Therapy, Department of Medicine Duke University Medical Center Durham NC U.S.A.

3. Duke Cancer Institute Duke University Medical Center Durham NC U.S.A.

4. Duke University School of Medicine Durham NC U.S.A.

5. Department of Pathology Duke University Medical Center Durham NC U.S.A.

6. Durham VA Medical Center Durham NC U.S.A.

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjd.18028

Reference8 articles.

1. Prospective evaluation of 2 acute graft-versus-host (GVHD) grading systems: a joint Societe Francaise de Greffe de Moelle et Therapie Cellulaire (SFGM-TC), Dana Farber Cancer Institute (DFCI), and International Bone Marrow Transplant Registry (IBMTR) prospective study

2. Inhibition of Toxic Epidermal Necrolysis by Blockade of CD95 with Human Intravenous Immunoglobulin

3. Role of Natural Killer Cells in Intravenous Immunoglobulin–Induced Graft-versus-Host Disease Inhibition in NOD/LtSz-scidIL2rg−/− (NSG) Mice

4. Complete FcRn dependence for intravenous Ig therapy in autoimmune skin blistering diseases

5. Expansion of CD4+CD25+ regulatory T cells by intravenous immunoglobulin: a critical factor in controlling experimental autoimmune encephalomyelitis

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rashes to Recognize in the Immunocompromised Transplant Patient: Focus on the Solid Organ Transplant Recipient;Emerging Transplant Infections;2021

2. Rashes to Recognize in the Immunocompromised Transplant Patient: Focus on the Solid Organ Transplant Recipient;Emerging Transplant Infections;2021

3. Neutropenia resulting from high‐dose intravenous immunoglobulin in dermatological patients;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2020-12

4. Neutropenie als Nebenwirkung der Therapie mit hochdosierten intravenösen Immunglobulinen in der Dermatologie;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2020-12